Evidence map›Paper›PMID 29463998›Full record

ArticleTheranostics2018

Octopod PtCu Nanoframe for Dual-Modal Imaging-Guided Synergistic Photothermal Radiotherapy.

Jinghua Li, Xiangyang Zu, Gaofeng Liang, KeKe Zhang, Yuliang Liu, Ke Li, Zhong Luo, Kaiyong Cai

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Theranostics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 41 citations in OpenAlex.

  1. PtNiSnOInternational journal of molecular sciences · 2025
    Article
  2. Article
  3. Article
  4. Application of nano-radiosensitizers in combination cancer therapy.Bioengineering & translational medicine · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jinghua LiSchool of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471023, China.
Xiangyang ZuSchool of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471023, China.
Gaofeng LiangSchool of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang 471023, China.
KeKe ZhangSchool of Materials Science and Engineering, Henan University of Science and Technology, Luoyang 471023, China.
Yuliang LiuSchool of Materials Science and Engineering, Henan University of Science and Technology, Luoyang 471023, China.
Ke LiKey Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400044, China.
Zhong LuoKey Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400044, China.
Kaiyong CaiKey Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400044, China.
Henan University of Science and Technology · CNChongqing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heavy atom nanoparticles have high X-ray absorption capacity and near infrared (NIR) photothermal conversion efficiency, which could be used as radio-sensitizers. We hypothesized that concave PtCu octopod nanoframes (OPCNs) would be an efficient nanoplatform for synergistic radio-photothermal tumor ablation.

Indexed as

Cell Line, TumorDiagnostic ImagingFolic AcidHumansHyperthermia, InducedModels, BiologicalNanocompositesNeoplasmsPhotoacoustic TechniquesPhotochemotherapyRadiotherapy, Image-GuidedTheranostic NanomedicineThermometryFolic Aciddual-modal imagingnear-infrared lightPtCu nanoframesynergistic tumor therapy.targeting

Identifiers

PMID29463998
PMCPMC5817109
OpenAlexW2782611234

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.